IS SUBCORTICAL DISEASE-ASSOCIATED WITH A POOR RESPONSE TO ANTIDEPRESSANTS - NEUROLOGICAL, NEUROPSYCHOLOGICAL AND NEURORADIOLOGICAL FINDINGSIN LATE-LIFE DEPRESSION
S. Simpson et al., IS SUBCORTICAL DISEASE-ASSOCIATED WITH A POOR RESPONSE TO ANTIDEPRESSANTS - NEUROLOGICAL, NEUROPSYCHOLOGICAL AND NEURORADIOLOGICAL FINDINGSIN LATE-LIFE DEPRESSION, Psychological medicine, 28(5), 1998, pp. 1015-1026
Background. Late-life depression is associated with increased subcorti
cal white matter hyperintensities. There is some evidence that they ar
e associated with a poorer response to acute treatment. Neurological s
igns and neuropsychological dysfunction are further evidence of abnorm
alities in the brain, but they have not been studied in relation to th
erapy resistance. Methods. A prospective study of 24 normal controls a
nd 75 consecutive elderly (aged 65 to 85) patients with DSM-III-R majo
r depression entered a naturalistic study of treatment. Assessment of
response to monotherapy and then lithium augmentation or ECT created t
hree outcome groups. Investigations included magnetic resonance brain
imaging, neuropsychological and neurological examination. Results. Res
ponse to monotherapy within 12 weeks was shown by 42.7%, a further 37.
3% responded to lithium augmentation or ECT within 24 weeks and 20 % h
ad responded poorly to all treatments at 24 weeks. Subcortical hyperin
tensities were significantly increased in the more resistant patients.
These included confluent deep white matter, multiple (> 5) basal gang
lia lesions and pontine reticular formation lesions. Most of the neuro
psychological impairment was restricted to the resistant groups and wa
s of a subcortico-frontal type. Extrapyramidal, frontal and pyramidal
neurological signs characterized the resistant groups. The combination
of extrapyramidal signs, pyramidal tract signs and impairment of moto
r hand sequencing strongly predicted resistance to 12 weeks of antidep
ressant monotherapy with 89 % sensitivity and 95% specificity. Conclus
ion. In late-life depression a poor response to antidepressant monothe
rapy can be expected in those patients with a frontal lobe syndrome, e
xtrapyramidal signs or if MRI T-2-weighted lesions are present in both
the basal ganglia and the pontine reticular formation.